Mon, 05/11/2020 - 05:10 |
WHO statement: Tobacco use and COVID-19 |
WHO |
Mon, 09/23/2019 - 13:29 |
World Lung Day 2019: Respiratory Groups Unite to Call for Healthy Lungs for All |
American Thorac... |
Wed, 12/12/2018 - 00:31 |
Medical researchers awarded $10.8m in Federal funding |
UWA |
Fri, 11/09/2018 - 11:24 |
Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease |
Viatris |
Thu, 11/08/2018 - 22:10 |
Once-daily Trelegy Ellipta gains expanded COPD indication in Europe |
GlaxoSmithKline |
Sun, 10/21/2018 - 23:52 |
Science Center and Biotech Leader CSL Behring Partner to Accelerate Academic Research in the Search for New Medicines and Possible Cures |
University City... |
Tue, 10/16/2018 - 08:34 |
Nicotine is hard to quit |
HelsinkiUniv |
Thu, 10/11/2018 - 14:58 |
Theravance Biopharma and Mylan Report Positive New Data from Multiple Studies of YUPELRI (revefenacin) at the 2018 CHEST Annual Meeting |
Viatris |
Sun, 10/07/2018 - 19:52 |
Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI (revefenacin) at the 2018 CHEST Annual Meeting |
Viatris |
Thu, 10/04/2018 - 13:34 |
#CalfHealth Campaign - Part 3 Having trouble with calf pneumonia on your farm? |
Ulster Farmers Union |
Wed, 10/03/2018 - 19:47 |
Positive phase III results for baloxavir marboxil in people at high risk of complications from influenza to be presented at IDWeek 2018 |
Rocheusa |
Tue, 09/25/2018 - 07:44 |
Let's unite on World Lung Day and call for global lung health action |
American Colleg... |
Fri, 09/21/2018 - 17:14 |
Cooking with Wood or Coal Is Linked to Increased Risk of Respiratory Illness and Death |
American Thorac... |
Fri, 09/21/2018 - 09:57 |
Trelegy Ellipta receives positive CHMP opinion supporting expanded COPD indication in Europe |
GlaxoSmithKline |
Mon, 09/17/2018 - 03:47 |
Print Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at the European Respiratory Society International Congress |
Viatris |
Mon, 09/10/2018 - 18:58 |
GSK data presented at ERS further supports its industry-leading respiratory medicines portfolio |
GlaxoSmithKline |
Wed, 08/01/2018 - 16:08 |
Boehringer Ingelheim achieves modest growth in the first half of 2018 |
Boehringer-Ingelheim |
Tue, 07/17/2018 - 05:47 |
Phase III CAPSTONE-2 study showed that baloxavir marboxil reduced symptoms in people at high risk of complications from the flu |
Rocheusa |
Mon, 06/11/2018 - 00:46 |
Mount Sinai Team Diagnoses Asthma With Nasal Brush Test |
Mount Sinai |
Thu, 06/07/2018 - 19:41 |
In dust and despair, displaced Syrians wait |
MSF |
Tue, 05/29/2018 - 06:24 |
GSK submits regulatory application in Japan for once-daily single inhaler triple therapy FF/UMEC/VI for patients with COPD |
GlaxoSmithKline |
Mon, 05/21/2018 - 10:11 |
GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma |
GlaxoSmithKline |
Mon, 05/21/2018 - 03:26 |
Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control |
GlaxoSmithKline |
Thu, 05/17/2018 - 17:21 |
Pig immunology comes of age: killer T cell responses to influenza |
University of B... |
Wed, 05/16/2018 - 03:04 |
GSKs industry-leading respiratory research and scientific innovation showcased at ATS conference |
GlaxoSmithKline |